| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/09/2013 | US8481528 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 07/09/2013 | US8481513 3, 10, and 12a substituted tetracycline compounds |
| 07/09/2013 | US8481489 GH secretagogues and uses thereof |
| 07/09/2013 | US8481318 Nestin-expressing hair follicle stem cells |
| 07/09/2013 | US8481091 Pharmaceutical compositions |
| 07/09/2013 | CA2761440C Fredericamycin derivatives |
| 07/09/2013 | CA2577408C Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators |
| 07/09/2013 | CA2567268C Thienopyridinone compounds and methods of treatment |
| 07/09/2013 | CA2527039C Grf analog compositions and their use |
| 07/09/2013 | CA2518171C Methods and compositions for the enzymatic synthesis of gangliosides |
| 07/09/2013 | CA2445565C Compositions and methods of double-targeting virus infections and cancer cells |
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling |
| 07/04/2013 | WO2013102195A1 Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives |
| 07/04/2013 | WO2013101949A2 Composition and method for compounded therapy |
| 07/04/2013 | WO2013101926A1 Benzimidazole derivatives as selective blockers of persistent sodium current |
| 07/04/2013 | WO2013101911A2 Benzimidazole derivatives as selective blockers of persistent sodium current |
| 07/04/2013 | WO2013101802A1 Nicotinic receptor compounds |
| 07/04/2013 | WO2013100874A1 Effervescent pregablin formulation |
| 07/04/2013 | WO2013100873A1 Pharmaceutical formulation of pregabalin (particle size 300-2500 micrometer) |
| 07/04/2013 | WO2013100870A1 New antipsychotic compositions |
| 07/04/2013 | WO2013100571A1 Phenyl carbamate compounds for use in preventing or treating als |
| 07/04/2013 | WO2013100570A1 Phenyl carbamate compounds for use in preventing or treating epilesy |
| 07/04/2013 | WO2013100569A1 Phenyl carbamate compounds for use in preventing or treating multiple sclerosis |
| 07/04/2013 | WO2013100567A1 Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain |
| 07/04/2013 | WO2013098588A1 Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies |
| 07/04/2013 | WO2013098570A1 Use of estrogen derivatives for the manufacture of pharmaceutical products useful for the prophylaxis and/or treatment of psychiatric diseases |
| 07/04/2013 | WO2013098415A1 Preparation for improving memory and learning and use thereof |
| 07/04/2013 | WO2013098374A1 1,3-diphenylpropane derivatives, preparations and uses thereof |
| 07/04/2013 | WO2013097947A1 Pipecolate-sulfonamides for treatment of psychiatric disorders |
| 07/04/2013 | WO2013097773A1 Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators |
| 07/04/2013 | WO2013066374A3 Humanin protection of dopaminergic neurons |
| 07/04/2013 | WO2013055385A3 Methods of treating age related disorders |
| 07/04/2013 | WO2013055127A3 Pharmaceutical composition for preventing and treating dementia, parkinson's disease or epilepsy, containing houttuynia cordata thunb. extract as active ingredient |
| 07/04/2013 | WO2013049725A3 Methods of using adenosine a1 receptor activation for treating depression |
| 07/04/2013 | WO2013049362A3 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis |
| 07/04/2013 | WO2013049026A4 Neurabin scaffolding of the adenosine receptor and rgs4 regulates anti-seizure effect of endogenous adenosine |
| 07/04/2013 | WO2013038195A3 Pharmaceutical nanoparticle compositions |
| 07/04/2013 | US20130172387 Method and composition for prolonging analgesic effect of local anesthetic |
| 07/04/2013 | US20130172382 Abuse-resistant controlled-release opioid dosage form |
| 07/04/2013 | US20130172322 Benzazepine derivatives useful for treatment of 5ht2c receptor associated diseases |
| 07/04/2013 | US20130171232 Heat Patch for Parkinson's Disease |
| 07/04/2013 | US20130171231 Heat Patch For Insomnia |
| 07/04/2013 | US20130171229 Implantable polymeric device for sustained release of buprenorphine |
| 07/04/2013 | US20130171157 NOGO Receptor-Mediated Blockade of Axonal Growth |
| 07/04/2013 | DE112011102409T5 Verfahren zur Behandlung der Alzheimer-Krankheit A method for the treatment of Alzheimer's disease |
| 07/04/2013 | DE112010005848T5 Amidverbindungen Amide compounds |
| 07/04/2013 | CA2858285A1 1,3-diphenylpropane derivatives, preparations and uses thereof |
| 07/04/2013 | CA2832465A1 Methods and compositions for treating parkinson's disease |
| 07/03/2013 | EP2610254A1 Deuterated benzoquinoline derivatives as inhibitors of vesicular monoamine transporter 2 |
| 07/03/2013 | EP2610247A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists |
| 07/03/2013 | EP2610246A1 Ethanamine compounds and methods of using the same |
| 07/03/2013 | EP2610245A1 Pipecolate-sulfonamides for treatment of psychiatric disorders |
| 07/03/2013 | EP2609929A1 Composition for preventing or treating dementia |
| 07/03/2013 | EP2609928A2 Use of cannabinoids in combination with an anti-psychotic medicament |
| 07/03/2013 | EP2609916A1 New therapeutic approaches for treating CMT and related disorders |
| 07/03/2013 | EP2609914A1 Novel methods for treating or preventing neurodegeneration |
| 07/03/2013 | EP2609812A1 Liquid nucleotides/nucleosides-containing product |
| 07/03/2013 | EP2609108A1 Certain chemical entities, compositions, and methods |
| 07/03/2013 | EP2609097A1 Pyridyl-amine fused azadecalin modulators |
| 07/03/2013 | EP2609093A1 Salt compound |
| 07/03/2013 | EP2609086A1 Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators |
| 07/03/2013 | EP2609085A1 Substituted quinoline-3-carboxamides as kcnq2/3 modulators |
| 07/03/2013 | EP2609084A1 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators |
| 07/03/2013 | EP2609083A1 Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators |
| 07/03/2013 | EP2608801A2 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
| 07/03/2013 | EP2608798A1 Plant extracts made of sideritis and use thereof to boost cognitive performance |
| 07/03/2013 | EP2608789A1 Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine |
| 07/03/2013 | EP2608787A1 Proline sulfonamide derivatives as orexin receptor antagonists |
| 07/03/2013 | EP2608786A2 Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin |
| 07/03/2013 | EP2608782A1 Novel use of leflunomide and malononitrilamides |
| 07/03/2013 | EP2608770A1 Inhalable gaseous drug containing krypton for treating neuro-intoxication |
| 07/03/2013 | CN103189393A Method for producing and using a copolymer of sodium carboxymethyl cellulose and gossypol |
| 07/03/2013 | CN103189370A Triazole derivatives as ligands for GABA receptors |
| 07/03/2013 | CN103189364A Dihydrooxazol-2-amine derivatives |
| 07/03/2013 | CN103189357A Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators |
| 07/03/2013 | CN103189350A Trans-2-decenoic acid derivative and medicament containing same |
| 07/03/2013 | CN103189337A Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 07/03/2013 | CN103189069A Treatment of neurodegenerative diseases by targeting miRNA |
| 07/03/2013 | CN103189062A Use of active pharmaceutical compounds for the treatment of central nervous system conditions |
| 07/03/2013 | CN103189060A Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 07/03/2013 | CN103189056A Treatment of L-DOPA, dopamine agonist and/or dopamine enhancer induced disorders |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 07/03/2013 | CN103183719A Saponin derivative and application thereof |
| 07/03/2013 | CN103183715A Furostan saponin derivative and purpose thereof |
| 07/03/2013 | CN103183660A Chromane derivative used as TRPV3 (transient receptor potential vanilloid 3) conditioning agent |
| 07/03/2013 | CN103183659A Chromane derivative used as TRPV3 (transient receptor potential vanillin 3) regulator |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/03/2013 | CN103182090A Dna疫苗 Dna Vaccine |
| 07/03/2013 | CN103182087A Trimethyl chitosan-graft-polyethylene glycol/nucleic acid brain-targeting micellar and preparation method thereof |
| 07/03/2013 | CN103182085A Methods and compositions for cellular drug release |
| 07/03/2013 | CN103182072A Application of interleukin-22 in treating and preventing nerve injuries and neurodegeneration diseases |
| 07/03/2013 | CN103182031A Health care Chinese medicinal composition |
| 07/03/2013 | CN103182030A Traditional Chinese medicine composition for treating insomnia |
| 07/03/2013 | CN103182028A Health care medicine |
| 07/03/2013 | CN103182005A Agilawood fumigating method |
| 07/03/2013 | CN103181972A Tablet or capsule of traditional Chinese medicine for treating wind-heat type common cold and upper respiratory infection, and preparation method thereof |
| 07/03/2013 | CN103181962A Traditional Chinese medicine effervescence particles for treating apoplexy sequela, and preparation method thereof |
| 07/03/2013 | CN103181954A Medicine composition used for treating neurodegenerative disease as well as preparation method and application thereof |
| 07/03/2013 | CN103181952A Roxburgh engelhardtia extractive for preventing and treating autoimmune diseases and preparation method thereof |
| 07/03/2013 | CN103181951A Application of pseudo-ginseng and maca composition to treatment of dizziness, headache and hand-foot numbness |